Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - atomoxetine hydrochloride 11.43mg equivalent to 10 mg atomoxetine free base - capsule - 10 mg - active: atomoxetine hydrochloride 11.43mg equivalent to 10 mg atomoxetine free base excipient: dimeticone gelatin pregelatinised maize starch sodium laurilsulfate tekprint black sw-9008 tekprint black sw-9010 titanium dioxide - strattera is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older and adolescents.

Singapour - anglais - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - atomoxetine hydrochloride eqv atomoxetine - capsule - 10 mg - atomoxetine hydrochloride eqv atomoxetine 10 mg

Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

eli lilly and company ltd - atomoxetine hydrochloride - oral capsule - 10mg

Australie - anglais - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - atomoxetine hydrochloride, quantity: 11.43 mg (equivalent: atomoxetine, qty 10 mg) - capsule, hard - excipient ingredients: titanium dioxide; pregelatinised maize starch; gelatin; sodium lauryl sulfate; dimeticone 350; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - strattera is indicated for the treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

Malte - anglais - Medicines Authority

eli lilly nederland b.v papendorpseweg 83, 3528 bj, utrecht, nl-3991, netherlands - atomoxetine - hard capsule - atomoxetine 10 mg - psychoanaleptics

Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eli lilly benelux sa-nv - atomoxetine hydrochloride 11,43 mg - eq. atomoxetine 10 mg - capsule, hard - 10 mg - atomoxetine hydrochloride 11.43 mg - atomoxetine

Jordanie - anglais - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة مستودع الادوية العربي - the arab drug store p.s.c - atomoxetine 10 mg - 10 mg

Malaisie - anglais - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - atomoxetine hydrochloride -

Israël - anglais - Ministry of Health

eli lilly israel ltd, israel - atomoxetine as hydrochloride - hard capsule - atomoxetine as hydrochloride 10 mg - atomoxetine - strattera is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. treatment must be initiated by a specialist in the treatment of adhd, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. diagnosis should be made according to current dsm criteria or the guidelines in icd.in adults, the presence of symptoms of adhd that were pre-existing in childhood should be confirmed. third-party corroboration is desirable and strattera should not be initiated when the verification of childhood adhd symptoms is uncertain. diagnosis cannot be made solely on the presence of one or more symptoms of adhd. based on clinical judgment, patients should have adhd of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’

Malte - anglais - Medicines Authority

eli lilly & co. limited - atomoxetine - hard capsule - atomoxetine 10 mg - psychoanaleptics